Did you hear? The world’s first once weekly #insulin will be available across the country soon! 💉🇨🇦 🔎Do you prescribe or dispense basal insulins? Stay ahead of the learning curve and sign up for our newest mini-series on MedEssist Hub! The landscape of #diabetes management is evolving quickly, and we're here to provide you with all the essential information about long-acting insulins. This includes the newly approved once weekly basal insulin, a groundbreaking advancement in diabetes care! 🚀 📚Brought to you in collaboration with @LMC Pharmacy and CDE pharmacists Brian Lam and Natalie Shing, part 1 in this 3-part mini-series focuses on the foundational knowledge of basal insulins to help you prepare for individuals starting or switching to once weekly insulin. Some of the learning points include: 💡The different basal insulins available on the market now 💡The pros and cons of each therapy 💡When basal insulin should be started 💡And more!! With our flexible and interactive online learning, there's no reason to delay! ⏳ It’s time to take control of your professional development and enhance patient care. 🏥 Enroll now to secure your spot! Check out the course in the comments below👇
MedEssist💊 | Transforming Pharmacy with Tech and AI’s Post
More Relevant Posts
-
Join us at ADCES and take the #MicronChallenge. Visit us at booth #825 to learn why Droplet Micron is the preferred pen needle brand for 2 out of 3 patients.* * Based on data from the PINNACLE study conducted in February 2024 with 108 patients, 82% of those patients surveyed declared a preference for Micron Pen needles over a comparison brand and reported decreased pain intensity as the main reason for preference (for 70% of respondents). 1 Data on File - As of 6.05.2024 of marketed pen needles in the USA, Canada Association of Diabetes Care & Education Specialists #adces24
-
-
"Honored to have participated in the 5th Annual Innovation in Pharmacy Conference, focusing on 'Effective Management of Type 1 Diabetes Mellitus: A Pharmacist's Perspective on Improving Patient Outcomes.' A big thank you to the organizers and collaborators for such an insightful session! Excited to apply these learnings to better serve patients in the healthcare system. #PharmacyInnovation #Type1Diabetes #PatientCare #ContinuousLearning"
-
-
Finding the right fluid balance in dialysis patients is complex, but our upcoming webinar focuses on the individualized approach that will help you improve these patient outcomes. Get a head start by exploring this article: https://lnkd.in/ebsX5bjR Learn all about it by registering now
-
Collaborative care involving pharmacists improves diabetes management and reduces cardiovascular risk in patients. #pharmacy #diabetes #ADASciSessions Watch Here: https://bit.ly/3xxhUEa
Managing Diabetes and Cardiovascular Risk Through Collaborative Care
-
Director of Experiential Education, Professor of Pharmacy Practice, Diabetes Care and Education Specialist.
📣Live CE Opportunity📣 From A1C to Z: A Sweet Update on Diabetes Guidelines by CEimpact! Join me in this live course where I review the latest ADA Standard of Care for Pharmacists and Technicians! Seats are limited - register using the links below! Tech: https://lnkd.in/gQV2R-BE Pharm: https://lnkd.in/gYgXWHhr Learning Objectives: 1. Summarize recent changes to the American Diabetes Association Management of Hyperglycemia in Type 1 and Type 2 Diabetes. 2. Discuss the rationale regarding therapeutic decision-making when selecting medication therapy for people with type 2 diabetes and its multi-morbidities. 3. Formulate patient-centered treatment plans for people with diabetes to reduce glucose, and improve cardiometabolic, kidney, liver, and cognitive health.
-
-
📣Live CE Opportunity📣 From A1C to Z: A Sweet Update on Diabetes Guidelines! This live course with Susan Cornell, PharmD. reviews the latest ADA Standard of Care for Pharmacists and Technicians! Seats are limited - register using the link below! Tech: https://lnkd.in/g7umPFga Pharm: https://lnkd.in/gjzbN3rm What we will cover during our LIVE CE program: 1. Summarize recent changes to the American Diabetes Association Management of Hyperglycemia in Type 1 and Type 2 Diabetes. 2. Discuss the rationale regarding therapeutic decision-making when selecting medication therapy for people with type 2 diabetes and its multi-morbidities. 3. Formulate patient-centered treatment plans for people with diabetes to reduce glucose, and improve cardiometabolic, kidney, liver, and cognitive health.
-
-
Medication Adherence: Strategies and Best Practices Improving the quality, safety and experience of care that patients receive is central to the Network’s mission and performance in Medicare Advantage (MA) value-based programs. Medication adherence quality measures are more heavily weighted in the MA Star Ratings and require medication adherence rates of 80% or higher for patients with diabetes, hypertension and cholesterol for each calendar year. To improve performance in these quality measures, the Network’s pharmacy team recommends four specific best practices for providers: 1. Know which medications are included in the medication adherence quality measures. 2. Partner with patients on purpose, side effects and cost. 3. For medications included in the medication adherence quality measures, extend the days’ supply and provide enough refills until the next intervention. 4. Help patients select a pharmacy that can impact adherence. https://lnkd.in/eWdQxMKR
-
Discover the game-changer in diabetes treatment - Glucagon-like peptide-1 (GLP-1) agonists. Why are GLP-1 agonists gaining traction? 1. Effective Blood Sugar Control 2. Weight Management 3. Possible Heart Health Benefits With great power comes the need for safety and expertise. These medications are prevalent in the news media and Pharmacy Benefit Management (PBM) industry, emphasizing the crucial role of pharmacists in ensuring patient safety. Contact us to learn more about how we manage GLP-1s for our members. https://lnkd.in/e_YsE5yt #GLP1Agonists #DiabetesManagement #PatientSafety #PharmacyInnovation #PBMClinicalReview #DiabetesTreatment #BloodSugarControl #PBF #PBM #WeightManagement #HeartHealth #PharmacyBenefitManagement
-
-
We love receiving feedback from our customers and were delighted to hear how the A1CNow+ device is making a difference to the Hartlepool Diabetes Group ⬇️ This is what Hayley Hakansson, the Group's Facilitator had to say: “𝘞𝘦 𝘵𝘦𝘴𝘵𝘦𝘥 𝘯𝘪𝘯𝘦 𝘮𝘦𝘮𝘣𝘦𝘳𝘴 𝘰𝘧 𝘰𝘶𝘳 𝘵𝘦𝘢𝘮 𝘶𝘴𝘪𝘯𝘨 𝘈1𝘊𝘕𝘰𝘸+ 𝘢𝘯𝘥 𝘵𝘩𝘦𝘺 𝘸𝘦𝘳𝘦 𝘢𝘮𝘢𝘻𝘦𝘥. 𝘛𝘩𝘦𝘺 𝘢𝘭𝘭 𝘴𝘢𝘪𝘥 𝘵𝘩𝘢𝘵 𝘵𝘩𝘦𝘪𝘳 𝘏𝘣𝘈1𝘤 𝘳𝘦𝘴𝘶𝘭𝘵 𝘸𝘢𝘴 𝘦𝘹𝘢𝘤𝘵𝘭𝘺 𝘵𝘩𝘦 𝘴𝘢𝘮𝘦 𝘢𝘴 𝘵𝘩𝘦𝘪𝘳 𝘳𝘦𝘤𝘦𝘯𝘵 𝘵𝘦𝘴𝘵 𝘳𝘦𝘴𝘶𝘭𝘵 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘥𝘰𝘤𝘵𝘰𝘳. 𝘞𝘦 𝘢𝘳𝘦 𝘨𝘰𝘪𝘯𝘨 𝘵𝘰 𝘳𝘦𝘱𝘦𝘢𝘵 𝘵𝘩𝘦 𝘦𝘹𝘦𝘳𝘤𝘪𝘴𝘦 𝘭𝘢𝘵𝘦𝘳 𝘵𝘩𝘪𝘴 𝘺𝘦𝘢𝘳 𝘢𝘯𝘥 𝘴𝘦𝘦 𝘸𝘩𝘢𝘵 𝘵𝘩𝘦 𝘳𝘦𝘴𝘶𝘭𝘵𝘴 𝘢𝘳𝘦 𝘪𝘯 6 𝘮𝘰𝘯𝘵𝘩𝘴’ 𝘵𝘪𝘮𝘦. 𝘌𝘷𝘦𝘳𝘺𝘰𝘯𝘦 𝘴𝘢𝘺𝘴 𝘪𝘵 𝘪𝘴 𝘢𝘯 𝘢𝘮𝘢𝘻𝘪𝘯𝘨 𝘴𝘺𝘴𝘵𝘦𝘮 𝘢𝘯𝘥 𝘪𝘵’𝘴 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵 𝘵𝘩𝘢𝘵 𝘸𝘦 𝘨𝘦𝘵 𝘵𝘩𝘦 𝘣𝘦𝘴𝘵 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘳𝘦𝘴𝘶𝘭𝘵𝘴 𝘧𝘳𝘰𝘮 𝘪𝘵. 𝘋𝘦𝘧𝘪𝘯𝘪𝘵𝘦𝘭𝘺 𝘸𝘰𝘳𝘵𝘩 𝘦𝘷𝘦𝘳𝘺 𝘱𝘦𝘯𝘯𝘺 𝘸𝘦 𝘩𝘢𝘷𝘦 𝘳𝘢𝘪𝘴𝘦𝘥 𝘵𝘰 𝘣𝘶𝘺 𝘪𝘵.” If you think the A1CNow+ device could make a difference to your patients, whether you're a #diabetes group, a #privateclinic or a #pharmacy, give us a call on 02476 377210 or email info@bhr.co.uk to find out more. 𝗔𝗯𝗼𝘂𝘁 𝗛𝗯𝗔𝟭𝗰 Haemoglobin is a protein component of the red blood cell and carries oxygen around the body. When haemoglobin joins with glucose, it becomes glycated to form glycated haemoglobin A (HbA1c or A1c). HbA1c gives a picture of a patient’s glucose levels over the previous 2-3 months and can indicate people with prediabetes or diabetes as follows: • Normal – less than 42 mmol/mol (6%) • Pre-diabetic – between 42 mmol/mol (6%) and 47 mmol/mol (6.5%) • Diabetic – more than 48 mmol/mol (6.5% or over) 𝗔𝗯𝗼𝘂𝘁 𝗔𝟭𝗖𝗡𝗼𝘄 Healthcare professionals can provide patients with a lab-comparable HbA1c test using the simple and easy-to-use A1cNow+ point-of-care testing device, giving a quantitative result in 5 minutes from a single drop of blood. • Small fingerstick blood sample (5µL) • Requires no maintenance or calibration • Can be stored at room temperature for 4 months #ivd #poct #poc #rapidtesting #diabetescare #hba1c
-
